Investigation of glial fibrillary acidic protein (GFAP) in body fluids as a potential biomarker for glioma: a systematic review and meta-analysis.

Jessy Van van Asperen Daria M Fedorushkova Pierre A J T Robe Elly M Hol

Published in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2021)

The presence of sGFAP is indicative of grade IV glioma, but additional studies are necessary to fully determine the usefulness of GFAP in body fluids as a tool for grade IV glioma diagnosis and follow-up.

Keyphrases

ionic liquid
amino acid
spinal cord injury